NCT04862052View on ClinicalTrials.gov

Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 26, 2021

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
Coronary Stent Restenosis
Interventions
PROCEDURE

Intravascular management of prior implanted coronary drug eluting stent restenosis

Intravascular devices will be assessed for the management of prior implanted drug eluting stent restenosis management.

Trial Locations (2)

1122

RECRUITING

Semmelweis University Heart and Vascular Center, Budapest

6725

RECRUITING

University of Szeged, Department of Invasive Cardiology, Szeged

All Listed Sponsors
lead

Semmelweis University Heart and Vascular Center

OTHER